Editorial Type:
Article Category: Research Article
| Online Publication Date: 23 Dec 2020
Full Issue PDF
Full Issue PDF
Page Range: i – xxiv
Copyright: Copyright © 2020 by Pulmonary Hypertension Association. All rights reserved.
Skip to main content
Article Contents
Rapid Transition From Oral Selexipag to Intravenous Treprostinil in a Patient With Severe Pulmonary Arterial Hypertension
Ruchi P. JainPharmD, FCCM,
Bo TangMD, and
Kumar SatyaMD, FRCP
A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension
Tina StiyerRN, BSN and
Scott H. VisovattiMD
Defining Disease Modification in Pulmonary Arterial Hypertension
Naomi HabibMD and
Sandeep SahayMD, MSc
Guest Editor’s Memo
Rachel K. HopperMD
Rapid Transition From Oral Selexipag to Intravenous Treprostinil in a Patient With Severe Pulmonary Arterial Hypertension
Ruchi P. JainPharmD, FCCM,
Bo TangMD, and
Kumar SatyaMD, FRCP
A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension
Tina StiyerRN, BSN and
Scott H. VisovattiMD
Defining Disease Modification in Pulmonary Arterial Hypertension
Naomi HabibMD and
Sandeep SahayMD, MSc
Guest Editor’s Memo
Rachel K. HopperMD
eISSN: 1933-0898
ISSN: 1933-088X
Powered by PubFactory